Marine Anthraquinones: Pharmacological and Toxicological Issues

Mar Drugs. 2021 May 13;19(5):272. doi: 10.3390/md19050272.

Abstract

The marine ecosystem, populated by a myriad of animals, plants, and microorganisms, is an inexhaustible reservoir of pharmacologically active molecules. Among the multiple secondary metabolites produced by marine sources, there are anthraquinones and their derivatives. Besides being mainly known to be produced by terrestrial species, even marine organisms and the uncountable kingdom of marine microorganisms biosynthesize anthraquinones. Anthraquinones possess many different biological activities, including a remarkable antitumor activity. However, due to their peculiar chemical structures, anthraquinones are often associated with toxicological issues, even relevant, such as genotoxicity and mutagenicity. The aim of this review is to critically describe the anticancer potential of anthraquinones derived from marine sources and their genotoxic and mutagenic potential. Marine-derived anthraquinones show a promising anticancer potential, although clinical studies are missing. Additionally, an in-depth investigation of their toxicological profile is needed before advocating anthraquinones as a therapeutic armamentarium in the oncological area.

Keywords: anthraquinones; anticancer mechanisms; cytotoxicity; fungi; genotoxicity; in vitro studies; in vivo studies; marine organisms.

Publication types

  • Review

MeSH terms

  • Animals
  • Anthraquinones / chemistry
  • Anthraquinones / pharmacology*
  • Anthraquinones / toxicity*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / toxicity*
  • Aquatic Organisms / chemistry*
  • Cell Line, Tumor
  • Humans
  • Mutagens / chemistry
  • Mutagens / pharmacology
  • Mutagens / toxicity
  • Neoplasms / drug therapy

Substances

  • Anthraquinones
  • Antineoplastic Agents
  • Mutagens